Possible new approach to treating prostate cancers
February 9th, 2010 Posted in prostate cancerResearchers at Loyola University Stritch School of Medicine developed treatments for prostate cancer based on on a workhorse protein called RSK
When activated, RSK is involved in cell survival, cell proliferation and cell enlargement.
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.
When activated, RSK is involved in cell survival, cell proliferation and cell enlargement, contributing towards cancer progression, heart enlargement and tumors associated with a genetic disease called Carney complex. Loyola researchers have discovered that a regulatory protein binds to RSK and effectively keeps RSK’s activity in check.